Retatrutide: Eli Lilly’s Next-Gen Triple-Agonist for Weight Loss and Diabetes
The landscape of metabolic medicine is shifting again as Eli Lilly advances its latest candidate, retatrutide, a drug that could redefine the ceiling for medical weight … Read more